文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

华南地区碳青霉烯耐药大肠埃希菌中blaCTX-M-199与PBP3插入共同导致氨曲南/阿维巴坦耐药

Emergence of Carbapenem-Resistant Escherichia coli Coharboring blaCTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究对华南地区291株碳青霉烯耐药大肠埃希菌(CREC)进行全基因组测序和药敏试验,发现8.9%(26/291)携带blaCTX-M-199,其中96.2%(25/26)对氨曲南/阿维巴坦(ATM/AVI)不敏感,38.5%(10/26)完全耐药。所有26株均同时携带blaNDM-5和PBP3的YRIK/YRIN插入,属于ST410和ST167高风险克隆,提示blaCTX-M-199与PBP3插入协同导致ATM/AVI耐药,需加强监测。

要点

  • 华南CREC中blaCTX-M-199检出率8.9%,多属ST410/ST167高风险克隆。
  • blaCTX-M-199阳性株96.2%对ATM/AVI不敏感,38.5%完全耐药。
  • blaCTX-M-199与PBP3插入协同降低ATM/AVI敏感性,需临床检测。

核心结论

  • blaCTX-M-199与PBP3的YRIK/YRIN插入协同导致CREC对ATM/AVI耐药,并在ST410和ST167高风险克隆中涌现。

研究设计与样本

  • 对华南地区291株临床CREC分离株进行全基因组测序(MLST、耐药基因、血清型、系统发育)和肉汤微量稀释法药敏试验,并通过滤膜接合试验评估质粒接合。

主要发现

  • 8.9%(26/291)的CREC菌株携带blaCTX-M-199。
  • 96.2%(25/26)的blaCTX-M-199阳性CREC对ATM/AVI不敏感,其中38.5%(10/26)完全耐药。
  • 所有26株blaCTX-M-199阳性菌株均携带blaNDM-5和PBP3的YRIK/YRIN插入,属于ST410(n=10)和ST167(n=16)。
  • blaCTX-M-199可位于染色体或可接合质粒上,接合子对ATM/AVI的MIC升高2-4倍。

临床怎么用

  • 临床应监测CREC中blaCTX-M-199的流行,并开展其检测以指导ATM/AVI等新型β-内酰胺/β-内酰胺酶抑制剂组合的用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infections caused by carbapenem-resistant Escherichia coli (CREC) pose a serious global public health threat due to limited therapeutic options. This study aimed to investigate the molecular epidemiology and the susceptibility to novel β-lactam/β-lactamase inhibitor combinations in clinical CREC isolates. METHODS: Whole-genome sequencing analysis including multilocus sequence types, antimicrobial resistance genes, serotypes and phylogeny was conducted. Antimicrobial susceptibility testing was performed by the broth microdilution method. Filter mating assays were performed to evaluate the conjugation of the plasmid. RESULTS: We identified an emerging extended-spectrum β-lactamase-encoding gene, blaCTX-M-199, in 8.9% (26/291) of CREC strains isolated in South China. Notably, 96.2% (25/26) of blaCTX-M-199-positive CREC strains exhibited aztreonam/avibactam (ATM/AVI) nonsusceptibility, with 38.5% (10/26) being fully resistant. All 26 blaCTX-M-199-positive strains harbored blaNDM-5 and YRIK/YRIN insertions of penicillin-binding protein 3, belonging to ST410 (n = 10) and ST167 (n = 16). Whole-genome sequencing revealed that blaCTX-M-199 can be located on the chromosome or on transferable plasmids. Transconjugants exhibited a 2- to 4-fold increase in the minimum inhibitory concentration of ATM/AVI. CONCLUSIONS: These findings suggest that blaCTX-M-199 contributes to reduced ATM/AVI susceptibility and, in synergy with YRIK/YRIN insertions, likely confers significant ATM/AVI resistance. Notably, CREC strains coharboring blaCTX-M-199 and YRIK/YRIN insertions are emerging within international high-risk clones ST410 and ST167. Therefore, our study highlights the importance of monitoring the prevalence of blaCTX-M-199-harboring CREC and implementing its detection in clinical practice.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wang J, Zhang X, Zhang Y, et al. Emergence of Carbapenem-Resistant Escherichia coli Coharboring blaCTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China. J Infect Dis. 2026. PMID: 41824657. doi:10.1093/infdis/jiag025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。